共 48 条
- [2] A need for biology-driven personalized radiotherapy in breast cancer [J]. Breast Cancer Research and Treatment, 2018, 167 : 603 - 604
- [4] Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: A retrospective analysis of 75 patients [J]. CANCER JOURNAL, 2006, 12 (02): : 113 - 122
- [5] Benchmarking Outcomes After Ablative Radiotherapy for Molecularly Characterized Unresectable Intrahepatic Cholangiocarcinoma [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S6 - S7
- [6] Phase I study of stereotactic radiotherapy for unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S170 - S171
- [7] Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (08): : 373 - 382
- [8] Dose-Escalated Ablative Radiotherapy as Definitive Treatment for Unresectable and Recurrent Intrahepatic Cholangiocarcinoma [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E178 - E178
- [9] Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option [J]. Annals of Surgical Oncology, 2010, 17 : 484 - 491